|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
2,630,000,000 |
Market
Cap: |
385.08(B) |
Last
Volume: |
5,016,259 |
Avg
Vol: |
8,298,662 |
52
Week Range: |
$144.38 - $174.48 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
DOW JONES COMPOSITE |
|
DOW JONES INDUSTRIAL AVERAGE |
|
NYSE COMPOSITE |
|
S&P 100 |
|
S&P 500 |
|
MAJOR MARKET |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 21 |
Guru Rank Value : 20.3 |
Guru Occurances : 6 |
|
|
|
|
|
|
|
Company Profile Johnson & Johnson is a holding company. Through its subsidiaries, Co. is engaged in the research and development, manufacture and sale of products in the health care field. Co. has three business segments: Consumer Health, which includes products focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women's health and wound care markets; Pharmaceutical, which is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension; and Medical Devices, which includes products used in the Interventional Solutions, Orthopaedics, Surgery, and Vision fields.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
8,891 |
68,288 |
115,451 |
513,708 |
Total Sell Value |
$1,441,765 |
$10,723,734 |
$18,652,688 |
$87,322,011 |
Total People Sold |
1 |
2 |
5 |
10 |
Total Sell Transactions |
1 |
2 |
5 |
23 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Hait William |
See Remarks |
|
2022-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,790 |
230,948 |
|
- |
|
Wengel Kathryn E |
EVP, Chief GSC Officer |
|
2022-02-14 |
4 |
D |
$168.85 |
$117,351 |
D/D |
(695) |
65,624 |
|
- |
|
Wengel Kathryn E |
EVP, Chief GSC Officer |
|
2022-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,896 |
66,319 |
|
- |
|
Duato Joaquin |
CEO |
|
2022-02-14 |
4 |
D |
$168.85 |
$397,811 |
D/D |
(2,356) |
229,165 |
|
- |
|
Duato Joaquin |
CEO |
|
2022-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,424 |
231,521 |
|
- |
|
Ullmann Michael H |
Exec VP, General Counsel |
|
2022-02-14 |
4 |
D |
$168.85 |
$147,068 |
D/D |
(871) |
151,858 |
|
- |
|
Ullmann Michael H |
Exec VP, General Counsel |
|
2022-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,407 |
152,729 |
|
- |
|
Broadhurst Vanessa |
EVP, Global Corp Aff. |
|
2022-02-14 |
4 |
D |
$168.85 |
$152,303 |
D/D |
(902) |
14,035 |
|
- |
|
Broadhurst Vanessa |
EVP, Global Corp Aff. |
|
2022-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,451 |
14,937 |
|
- |
|
Mcevoy Ashley |
EVP, WW Chair, Medical Devices |
|
2022-02-14 |
4 |
D |
$168.85 |
$133,729 |
D/D |
(792) |
32,249 |
|
- |
|
Mcevoy Ashley |
EVP, WW Chair, Medical Devices |
|
2022-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,885 |
33,041 |
|
- |
|
Gorsky Alex |
Director |
|
2022-01-14 |
4 |
D |
$167.84 |
$25,334,273 |
D/D |
(150,943) |
544,658 |
|
- |
|
Gorsky Alex |
Director |
|
2022-01-14 |
4 |
OE |
$65.37 |
$15,162,637 |
D/D |
231,951 |
695,601 |
|
- |
|
Duato Joaquin |
CEO |
|
2022-01-14 |
4 |
D |
$167.84 |
$9,126,804 |
D/D |
(54,378) |
226,097 |
|
- |
|
Duato Joaquin |
CEO |
|
2022-01-14 |
4 |
OE |
$65.37 |
$5,518,732 |
D/D |
84,423 |
280,475 |
|
- |
|
Hait William |
See RemarksOfficer |
|
2022-01-03 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
15,996 |
|
- |
|
Hait William |
See RemarksOfficer |
|
2022-01-03 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
71,609 |
|
- |
|
Swanson James D. |
EVP, Chief Information Officer |
|
2022-01-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,084 |
|
4% |
|
Broadhurst Vanessa |
EVP, Global Corp Aff.Officer |
|
2022-01-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,486 |
|
4% |
|
Hait William |
See RemarksOfficer |
|
2022-01-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
223,158 |
|
4% |
|
Mammen Mathai |
EVP, Pharm, R&DOfficer |
|
2022-01-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
32,477 |
|
4% |
|
Gorsky Alex |
Director |
|
2021-12-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
12,640 |
463,650 |
|
- |
|
Decker Robert J |
Controller, CAO |
|
2021-12-07 |
4 |
S |
$163.21 |
$816,050 |
D/D |
(5,000) |
14,215 |
|
-12% |
|
Decker Robert J |
Controller, CAO |
|
2021-12-07 |
4 |
OE |
$72.54 |
$362,700 |
D/D |
5,000 |
19,215 |
|
- |
|
Ullmann Michael H |
Exec VP, General Counsel |
|
2021-06-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
912 |
150,322 |
|
- |
|
1526 Records found
|
|
Page 10 of 62 |
|
|